Journal: Cardiovascular Research
Article Title: ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport
doi: 10.1093/cvr/cvae068
Figure Lengend Snippet: ATP13A3 deficiency impairs polyamine transport in ECs. ( A ) Cellular PUT, SPD, and SPM levels in hPAECs measured by LC–MS. Cells were transfected with DharmaFECT 1™ (DH1, Cambridge, UK) alone, si ATP13A3 , or non-targeting siRNA control (siCP) and cultured overnight in EBM2 containing 2% FBS supplemented with or without 1 mM PUT, 10 µM, SPD, or 10 µM SPM. The data ( n = 3 experiments) are presented as polyamine peak area ratio relative to 2% FBS DH1. ( B ) Western blot showing ATP13A3 protein expression in parental, non-transduced, and HMEC-1 cells stably expressing miRNAs targeting ATP13A3 (miR1–miR4), with miR-FLUC (Firefly Luciferase) as a control. ( C ) BDP-labelled polyamine uptake in HMEC-1 stable knockdown lines ( n = 4 experiments, two technical replicates per experiment). The data are normalized to the mean fluorescent intensities of miR-FLUC. ( D ) Confocal microscopy depicting the uptake and distribution of PUT-BDP in HMEC-1 cells, expressing miR-FLUC and ATP13A3 miR3 following 2 h treatment with PUT-BDP (scale bar = 10 µm). ( A , C ) The data (mean ± SEM) were analysed using a one-way ANOVA with Tukey’s post hoc test for multiple comparisons. * P < 0.05, ** P < 0.01, **** P < 0.0001.
Article Snippet: BODIPY-tagged spermine (SPM-BDP), spermidine (SPD-BDP), and putrescine (PUT-BDP) were synthesized, as previously described, and dissolved in 0.1 M 3-morpholinopropane-1-sulfonic acid (MOPS), pH = 7.0 (AppliChem, A1076, Darmstadt, Germany).
Techniques: Liquid Chromatography with Mass Spectroscopy, Transfection, Cell Culture, Western Blot, Expressing, Stable Transfection, Luciferase, Confocal Microscopy